Skip to content
FrontierPicks

Dossier · OLPX · Dormant

OLPX · Olaplex Holdings, Inc. · Stock research

Last analysed ·

Current thesis

Closed by event and now confirmed from the buyer's side: Henkel's all-cash takeout completed 2026-07-07 at $2.06 per share, Nasdaq delisting and a Form 15-12G followed, and Henkel's 2026-08-06 half-year report carries no brand-level Olaplex disclosure beyond a ~€370M annual-sales line. Last bar was $2.07 on 2026-07-06. No listed security, no float, no catalyst — a historical entry, not a candidate.

Kill line

No Henkel communication through the 2026-08-06 half-year report re-lists the brand, so the binary has come and gone with nothing left to grade.

Pick status

Open commitment catalyst 113d agoscored if the kill line above fires How this is scored →

Latest analysis and events for OLPX —

As of 23 August 2026, the latest FrontierPicks analysis for Olaplex Holdings, Inc. (OLPX): Closed by event and now confirmed from the buyer's side: Henkel's all-cash takeout completed 2026-07-07 at $2.06 per share, Nasdaq delisting and a Form 15-12G followed, and Henkel's 2026-08-06 half-year report carries no brand-level Olaplex disclosure beyond a ~€370M annual-sales line. Last bar was $2.07 on 2026-07-06. No listed security, no float, no catalyst — a historical entry, not a candidate.

Kill line: No Henkel communication through the 2026-08-06 half-year report re-lists the brand, so the binary has come and gone with nothing left to grade.

Most recent dated event on file: — catalyst 113d ago.

Current Thesis

The name is closed by event, and the first disclosure from the acquirer has now landed without reopening it. Henkel completed its all-cash acquisition before the open on 2026-07-07; every outstanding share was converted into the right to receive $2.06 in cash and cancelled, and the stock was removed from the Nasdaq Global Select Market that day. A Form 15-12G has since terminated SEC registration and suspended periodic reporting. The last completed daily bar in the adjusted series is $2.07 on 2026-07-06, a cent through the deal price.

What has changed since the prior write-up on 2026-08-15 is Henkel's half-year report, published 2026-08-06. Group sales of €10.3bn, organic growth +3.2% in H1 with Q2 at +4.7%; adjusted EBIT of €1,620M at a 15.7% margin, up 10 basis points; full-year 2026 organic sales guidance raised to 1.5–3.5% from 1.0–3.0%, with an adjusted EBIT margin range of 14.5–16.0%. Hair grew 4.2% organically in H1 and was named the main growth driver inside Consumer Brands. OLAPLEX appears in that release as a descriptive line — roughly €370M of annual sales and a global number-two position in professional hair — with no brand-level revenue, margin or growth figure attached. Measured: the deal closed 2026-07-07 and the reporting period ended 2026-06-30. Inferred from those two dates: none of the H1 figures contain Olaplex, so the brand's first appearance in any consolidated number is a future Henkel period.

The narrative is dead, dated 2026-07-07 — the conversion and delisting. The story was not broken by the tape; the security was extinguished at a fixed cash number, which is how a binary resolving in the acquirer's favour ends.

Bullish and bearish views on Olaplex Holdings, Inc.

The model's bull view on Olaplex Holdings, Inc. (OLPX), in brief: Consideration paid in full and on the agreed terms: $2.06 per share in cash effective 2026-07-07, against an announced transaction value of roughly $1.4B, with no downward revision to the price struck on 2026-03-26. The bear view: The instrument no longer exists: delisted 2026-07-07, with Form 15-12G terminating Section 12(g) registration. Both cases follow in full.

Bull Case

  • Consideration paid in full and on the agreed terms: $2.06 per share in cash effective 2026-07-07, against an announced transaction value of roughly $1.4B, with no downward revision to the price struck on 2026-03-26.
  • The regulatory path produced no friction: Bundeskartellamt clearance 2026-06-16 on a 2026-05-15 filing; Australia's ACCC followed around 2026-06-20; US and UK gates were satisfied in the final days of June, with no published second request and no drift toward the 2027 outside date.
  • Operations gave the buyer no walk-away hook: Q1 2026, reported 2026-05-11, showed net sales of $99.4M (+2.5% YoY), gross margin 72.1%, Professional +12.3%, DTC +13.8% — the first positive group comparison after a multi-year decline. At 2026-03-31, cash of $326.2M stood against $352.5M of long-term debt.
  • The brand is being described as an asset, not a problem, in the buyer's own reporting: the 2026-08-06 release frames OLAPLEX as innovation and cross-selling optionality inside Consumer Brands. That is commentary about Henkel's equity, and every item above is settled history — there is no forward leg here, because there is no forward security.

Bear Case

  • The instrument no longer exists: delisted 2026-07-07, with Form 15-12G terminating Section 12(g) registration. No 10-Q covering the June quarter will be filed; the Q1 FY2026 10-Q for the period ended 2026-03-31 stands as the last periodic report.
  • Zero residual optionality: no float, no options chain, no post-settlement short-interest print. The historically heavy short base — roughly 18–22% of float in the pre-deal era — was retired at $2.06 alongside every long.
  • the +2.5% group figure rested entirely on Professional and DTC.
  • Brand-level signal is now diluted to near nothing: ~€370M of annual Olaplex sales report inside a group that booked €10.3bn in a single half. Henkel's 2026-08-06 report gave Hair a segment growth number and gave Olaplex a sentence.
  • The full-cycle arithmetic: public in September 2021 near $21, cashed out at $2.06 under five years later. The decline was resolved by sale, never by operating recovery.

Setup & Price Structure

Every technical reading on this ticker is frozen at the terminal bar and should be read as an artifact, not a signal. The pipeline's own adjusted series stops at $2.07 on 2026-07-06: that print is simultaneously the last close and the 52-week high, so distance from the high reads 0.0%, the three-month change reads +2.0%, and RSI(14) sits at 66.7. That combination — pinned at the high, no drawdown, momentum in the 60s — is exactly the shape that pulls a delisted ticker back into screens.

The structure behind it is deal mechanics rather than accumulation. From the 2026-03-26 announcement, the shares traded in a one-to-two cent band around the $2.06 consideration, having closed near $1.33 on 2026-03-25 before the ~55% premium was struck. The final session settling a cent above the cash price is where a spread finishes when the market prices closing risk at essentially zero.

On crowding and positioning, the observable is the absence of observables: after the Form 15-12G there are no Form 4s, no short-interest prints, no institutional 13F position that resolves to a live security, and no earnings date. Retail-sentiment coverage of the ticker also stops; the most recent item in the feed is a 2026-04-14 momentum-screen piece from the pre-close window.

Catalyst Calendar (next 30 days)

  • 2026-08-23 → 2026-09-22 — nothing dated. No OLPX earnings, filing, index event or corporate action can occur; registration is terminated and the entity is a subsidiary of Henkel US Operations Corporation.

Elapsed catalysts

  • ~2026-11 (est.) — Henkel nine-month statement. First consolidated period that includes Olaplex, since the deal closed 2026-07-07. The single checkable question left is whether Henkel discloses any brand-level Olaplex figure or leaves it inside the Hair line. (passed 50d ago)
  • Already elapsed, for the record: 2026-05-05 (the last shareholder-vote-window catalyst carried in earlier coverage), 2026-05-11 (final quarterly report), 2026-07-07 (conversion and delisting), 2026-08-06 (Henkel H1). (passed 20d ago)

What Would Change Our Mind

Only one thing reopens this: a listed OLPX security existing again, which would require Henkel to spin, carve out or re-IPO the brand. No Henkel communication through the 2026-08-06 half-year release mentions such a step, and the brand was placed inside Consumer Brands rather than held separately. Absent that, the read cannot be updated by price at all — a daily close below $2.06 can no longer print, because the shares were converted to cash and removed from the exchange on 2026-07-07.

Two things would change the framing without changing the conclusion. First, a Henkel disclosure that breaks out Olaplex revenue or margin separately would restore a brand-level fundamental to track — through a Frankfurt-listed security. Second, any OLPX bar dated after 2026-07-06 appearing in a feed should be treated as a stale-vendor artifact and checked against the delisting date before it is used in any screen.

Correlation Notes

  • Henkel AG & Co. KGaA (Frankfurt; ADR) is the only remaining exposure route to the brand, and it is a poor one for a brand-level view: Olaplex's ~€370M of annual sales sit against €10.3bn of half-year group revenue, alongside Adhesive Technologies and the rest of Consumer Brands. Henkel's stock now trades on its 1.5–3.5% organic growth guide and 14.5–16.0% margin band, not on hair-bond chemistry.
  • Prestige-beauty comparables for the turnaround theme remain the distressed bucket — COTY, EL — rather than the momentum cohort. The relevant read-across from this deal is a strategic-buyer clearing price for a broken beauty IPO, and one transaction is not a valuation floor for names with no announced bidder.
  • Special-situation cohort: the value of this entry now is as a completed-deal reference point — announced 2026-03-26 at a ~55% premium, cleared four jurisdictions in about three months, closed 2026-07-07 with the spread never widening materially. Useful as a base-rate observation on strategic consumer M&A, not as an active exposure.

Notes

  • No US-listed equity exists after 2026-07-07; exposure to the brand is only available via Henkel's Frankfurt listing or its ADR.
  • Form 15-12G terminates SEC registration: no further 10-Q, 10-K, Form 4 or short-interest data will be published for Olaplex.
  • Any OLPX chart still served by a vendor terminates at the 2026-07-06 close of $2.07; later bars are stale-feed artifacts.
  • Frozen technicals read as 0.0% from the 52-week high with RSI(14) 66.7 — screen-catching values produced by a terminal bar, not by trading.
  • IPO September 2021 near $21, cashed out at $2.06 in under five years; the decline was resolved by sale, not by operating recovery.

Related · shared themes

HUM

Humana Inc.

Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.

MEDIUM

IRDM

Iridium Communications Inc

Deal-arb: $27.00 cash plus a collared RKLB stock leg marks a $54.00 package against the 2026-08-24 close of $47.30, a 12.41% discount. The S-4/A filed 2026-08-24 finally dated the special meeting (2026-09-24), but RKLB at $68.28 sits just 1.16% above the $67.50 collar floor — below it the package floats one-for-one with the acquirer.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM

CNC

Centene Corporation

Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.

LOW

See also · stocks to watch